and attached as Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such a filing. The fact that the information and Exhibit are being furnished should not be deemed an admission as to the materiali…

The filing is about an amendment to the Stock Award Plan, not a management change.

Results of Operations and Financial Condition. On May 6, 2026, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended March 31, 2026 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Entry into a Material Definitive Agreement. On April 16, 2026, OraSure Technologies, Inc. (the “Company”) announced its entry into a cooperation agreement (the “Cooperation Agreement”) with Altai Capital Management, L.P. and Altai Capital Management, LLC (collectively, “Altai”). Pursuant to the Cooperation Agreement, Altai irrevocably withdraws its prior notice, nominations, and stockholder proposal, effective upon execution of the Cooperation Agreement. Additionally, pursuant to the Cooperat…

Director — John D. Bertrand: Appointment of a new director to the Board.

Director — David J. Shulkin, M.D.: Dr. Shulkin resigned from his position as director.

Results of Operations and Financial Condition. On February 25, 2026, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the full year and quarter ended December 31, 2025 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Other Events On December 1, 2025, OraSure Technologies, Inc. (the “Company”) reported that each of Carrie Eglinton Manner, President, Chief Executive Officer and Director, and Kenneth McGrath, Chief Financial Officer, adopted separate Rule 10b5-1 trading plans for purchases of the Company’s common stock. As a result of the Company’s ongoing share repurchase program, purchases are subject to the parameters of the Rule 10b5-1 trading plans, which were adopted in accordance with Rule 10b5-1 unde…

Results of Operations and Financial Condition. On November 5, 2025, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended September 30, 2025 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Chair of the Board — Mara G. Aspinall: Ms. Aspinall resigned from her position as director and chair of the Board.

Results of Operations and Financial Condition. On August 5, 2025, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended June 30, 2025 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The filing pertains to an amendment and restatement of the Stock Award Plan, not a management change.

Chief Product Officer — Kathleen G. Weber: Ms. Weber resigned as Chief Product Officer for 'Good Reason'.

Results of Operations and Financial Condition. On May 7 2025, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended March 31, 2025 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Other Events. On March 24, 2025, OraSure Technologies, Inc. issued a press release announcing the authorization and approval, by the Company’s board of directors (the “Board”) on March 21, 2025, of a stock repurchase program for up to $40 million of shares of the Company’s common stock, par value $0.000001 per share (“Common Stock”) for a period of two years (the “Stock Repurchase Plan”). Concurrently with such authorization and approval, the Company terminated the existing repurchase program…

Results of Operations and Financial Condition. On February 25, 2025, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the full year and quarter ended December 31, 2024 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Entry into a Material Definitive Agreement. On December 19, 2024, OraSure Technologies, Inc., a Delaware corporation (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with, Project Watson Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), Sherlock Biosciences, Inc., a Delaware corporation (“Sherlock”), and Mr. Paul Meister, solely in his capacity as representative of the securityholders of Sherlock for cert…

Forward Looking Statements This Current Report contains certain “forward-looking statements” within the meaning of the Federal securities laws, including with respect to products, product development and manufacturing activities, the Company’s acquisition of Sherlock, revenue growth, cash flow, increasing margins and other matters. Words such as “expects,” “estimates,” “forecasts,” “intends,” “plans,” “projects,” “could,” “may,” “should,” “will” or other similar words and expressions are inte…

Other Events. On December 19, 2024, the Company issued a press release announcing the Company’s acquisition of Sherlock Biosciences, Inc (“Sherlock”). A copy of the press release is attached as Exhibit 99.2 to this Current Report and is incorporated herein by reference. Forward Looking Statements This Current Report contains certain “forward-looking statements” within the meaning of the Federal securities laws, including with respect to products, product development and manufacturing activiti…

Results of Operations and Financial Condition. On November 6, 2024, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended September 30, 2024 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Director — John P. Kenny: Appointment of a new director to the board.

Results of Operations and Financial Condition. On August 6, 2024, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended June 30, 2024 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The filing is about an amendment to the Stock Award Plan, not a management change.

Results of Operations and Financial Condition. On May 8, 2024, OraSure Technologies, Inc. (the “Company”) issued a press release announcing its consolidated financial results for the quarter ended March 31, 2024 and certain other matters. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

Regulation FD Disclosure. The Company reiterates its previously communicated financial guidance regarding its revenue for the first quarter of 2024. The information in this Item shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information and Exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by spe…